NEW YORK (GenomeWeb) – Epigenomics announced today that the US Food and Drug Administration has approved the company's blood-based colorectal cancer screening test Epi proColon.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.